New guidelines for cardiovascular management in noncardiac surgery released

The 2024 guideline for cardiovascular management of adults undergoing noncardiac surgery reflects a decade of updates and new evidence since the guideline’s last release in 2014.

FDA hands CRL to Merck’s chronic cough drug over efficacy questions

The FDA handed a complete response letter (CRL) on Wednesday to Merck for its cough drug gefapixant following an adcomm that voted against the drug

December 22, 2023

GSK to pay $2.2 billion to settle most Zantac lawsuits over claims the heartburn pill causes cancer

After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the

October 9, 2024

Penn researchers aim to uncover the underlying biological mechanisms of TBI-related neurodegeneration

A team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer’s disease and related dementias (ADRD) over

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.